An overview of familial Mediterranean fever with emphasis on pyrin and colchicine

Journal Medical Libanais

Volumn 56, Issue 1, 2008, Pages 35-41

  Dbouk, Hashem A ^a   Uthman, Imad W ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CELL PROTEIN; COLCHICINE; PROTEIN PYRIN; UNCLASSIFIED DRUG;

ALLOGENIC BONE MARROW TRANSPLANTATION; AMYLOIDOSIS; APOPTOSIS; AZOOSPERMIA; CHROMOSOME 16; CLINICAL FEATURE; DIARRHEA; DISEASE CARRIER; FAMILIAL MEDITERRANEAN FEVER; GENE EXPRESSION; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; MALABSORPTION; MISSENSE MUTATION; MORBIDITY; OLIGOSPERMIA; PHENOTYPE; PROTEIN DOMAIN; REVIEW;

ADOLESCENT; ADULT; ALLELES; CHILD; CHILD, PRESCHOOL; COLCHICINE; CYTOSKELETAL PROTEINS; DNA MUTATIONAL ANALYSIS; EXONS; FAMILIAL MEDITERRANEAN FEVER; GENETICS, POPULATION; GENOTYPE; HUMANS; INFANT; LEBANON; PHENOTYPE; TUBULIN MODULATORS;

EID: 41149163701     PISSN: 00239852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Kastner DL. Familial Mediterranean fever : the genetics of inflammation. Hosp Pract (Minneap) 1998 ; 33 : 131-4, 139-40, 143-6 passim.
2. Samuels J, Aksentijevich I, Torosyan Y et al. Familial Mediterranean fever at the millennium : clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine 1998 ; 77 : 268-98.
3. Gumucio DL, Diaz A, Schaner P et al. Fire and ICE : the role of pyrin domain-containing proteins in inflammation and apoptosis. Clin Exp Rheumatol 2002 ; 20 (Suppl 26) : S45-S53.
4. Stehlik C, Reed JC. The PYRIN connection : novel players in innate immunity and inflammation. J Exp Med 2004 ; 200 : 551-8.
5. El-Shanti H, Abdel Majeed H, El-Khateeb M. Familial Mediterranean fever in Arabs. The Lancet 2006 ; 367 : 1016-21.
6. Shinkai K, Kilcline C, Connoly MK, Frieden IJ. The pyrin family of fever genes. Arch Dermatol 2006 ; 141 : 242-7.
7. Siegal S. Benign paroxysmal peritonitis. Ann Intern Med 1945 ; 23 : 1-21.
8. Centola M, Aksentijevich I, Kastner DL. The hereditary periodic fever syndromes : molecular analysis of a new family of inflammatory diseases. Human Molecular Genetics 1998 ; 7 : 1581-8.
9. Cattan D. MEFV mutation carriers and diseases other than familial Mediterranean fever : proved and non-proved associations ; putative biological advantage. Current Drug Targets - Inflammation & Allergy 2005 ; 4 : 105-12.
10. Uthman I, Hajj-Ali RA, Arayssi T, Masri AF, Nasr F. Arthritis in familial Mediterranean fever. Rheumatol Int 2001 ; 20 : 145-8.
11. Lidar M, Kedem R, Mor A, Levartovsky D, Langevitz P, Livneh A. Arthritis as the sole episodic manifestation of familial Mediterranean fever . J Rheumatol 2005 ; 32 : 859-62.
12. Ben-Chitrit E, Levy M. Familial Mediterranean fever. The Lancet 1998 ; 351 : 659-64.
13. Buskila D, Zaks N, Neumann L et al. Quality of life of patients with familial Mediterranean fever. Clin Exp Rheumatol 1997 ; 15 : 355-60.
14. Gedalia A, Zamir S. Neurologic manifestations in familial Mediterranean fever. Pediatr Neurol 1993 ; 9 : 301-2.
15. Vilaseca J, Tor J, Guardia J, Bacardi R. Periodic meningitis and familial Mediterranean fever. Arch Intern Med 1982 ; 142 : 378-9.
16. Karachlion I, Karachlios G, Charalabopoulous A, Charalabopoulous K. Meningitis associated with familial Mediterranean fever. Int J Clin Pract Suppl 2005 ; 147 : 60-1.
17. Diaz A, Hu C, Kastner DL et al. Lipopolysaccharide-induced expression of multiple alternatively spliced MEFV transcripts in human synovial fibroblasts. Arthritis & Rheumatism 2004 ; 50 : 3679-89.
18. Erken E, Ozer THE, Gunesacar R. Plasma interleukin-10 and interleukin-12 levels in patients with familial Mediterranean fever. Rheumatol Int 2006 ; 26 : 862-4.
19. Baykal M, Saglam K, Yilmaz MI, Taslipinar A, Akinci SB, Inal A. Serum sIL-2r, IL-6, IL-10 and TNF-α level in familial Mediterranean fever patients. Clin Rheumatol 2003 ; 22 : 99-101.
20. Lachmann HJ, Sengul B, Yavuzsen TU et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 2006 ; 45 : 746-50.
21. Musabak U, Sengul A, Oktenli C et al. Does immune activation continue during an attack-free period in familial Mediterranean fever ? Clin Exp Immunol 2004 ; 138 : 526-33.
22. Ben-Chetrit E. Familial Mediterranean fever (FMF) and renal AA amyloidosis : phenotype-genotype correlation, treatment and prognosis. J Nephrol 2003 ; 16 : 431-4.
23. Livneh A, Langevitz P, Zemer D et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997 ; 40 : 1879-85.
24. Pras EAI, Gruberg L, Balow JE et al. Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. N Eng J Med 1992 ; 326 : 1509-13.
25. International FMF consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997 ; 90 : 797-807.
26. French FMF consortium. A candidate gene for familial Mediterranean fever. Nature Genetics 1997 ; 17 : 25-31.
27. Touitou I, Lesage S, McDermott M et al. Infevers : an evolving mutation database for auto-inflammatory syndromes. Hum Mutat 2004 ; 24 : 194-8.
28. Munding C, Keller M, Niklaus G et al. The estrogen-responsive B-box protein : a novel enhancer of interleukin-1β secretion. Cell Death and Differentiation 2006 ; 13 : 1938-49.
29. Chae JJ, Wood G, Masters SL et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1β production. P.N.A.S. USA 2006 ; 103 : 9982-7.
30. Fairbrother WJ, Gordon NC, Humke EW et al. The PYRIN domain : a member of the death domain-fold superfamily. Protein Science 2001 ; 10 : 1911-18.
31. Shoham NG, Centola M, Mansfield E et al. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. P.N.A.S. USA 2003 ; 100 : 13501-6.
32. Rao KM, Meighan T. Exposure in vivo to silica or lipopolysaccharide produces transient or sustained upregulation, respectively, of PYPAF7 and MEFV genes in bronchoalveolar lavage cells in rats. J Toxicol Environ Health A 2006 ; 69 : 481-90.
33. Grutter C, Briand C, Capitani G et al. Structure of the PRYSPRY-domain : implications for autoinflammatory diseases. FEBS letters 2006 ; 580 : 99-106.
34. Woo JS, Imm JH, Min CK, Kim KJ, Cha SS, Oh BH. Structural and functional insights into the B30.2/SPRY domain. The EMBO Journal 2006 ; 25 : 1353-63.
35. Sarkar A, Duncan M, Hart J, Hertlein E, Guttridge DC, Wewers MD. ASC directs NF-κB activation by regulating receptor interacting protein-2 (RIP2) caspase-1 interactions. The Journal of Immunology 2006 ; 176 : 4979-86.
36. Martinon F, Burns K, Tschopp J. The inflammasome : a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol Cell 2002 ; 10 : 417-26.
37. Mansfield E, Chae JJ, Komarow HD et al. The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments. Blood 2001 ; 98 : 851-9.
38. Chae JJ, Komarow HD, Cheng J et al. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell 2003 ; 11 : 591-604.
39. Ozen S, Hoffman HM, Frenkel J, Kastner D. Familial Mediterranean fever (FMF) and beyond : a new horizon. Ann Rheum Dis 2006 ; 65 : 961-4.
40. Richards N, Schaner P, Diaz A et al. Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis. J Biol Chem 2001 ; 276 : 39320-9.
41. Kutlay S, Sengul S, Keven K, Erturk S, Erbay B. Two sisters with familial Mediterranean fever : lack of correlation between genotype and phenotype ? J Nephrol 2006 ; 19 : 104-7.
42. Dewalle M, Domingo C, Rozenbaum M et al. Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fevel (FMF). Eur J Hum Genet 1998 ; 6 : 95-7.
43. Delibas A, Oner A, Balci B et al. Genetic risk factors of amyloidogenesis in familial Mediterranean fever. American Journal of Nephrology 2005 ; 25 : 434-40.
44. Medlej-Hashim M, Serre JL, Corbani S et al. Familial Mediterranean fever (FMF) in Lebanon and Jordan : a population genetics study and report of three novel mutations. European Journal of Medical Genetics 2005 ; 48 : 412-20.
45. Shohat M, Magal N, Shohat T et al. Phenotype-genotype correlation in familial Mediterranean fever : evidence for an association between Met694Val and amyloidosis. European Journal of Human Genetics 1999 ; 7 : 287-92.
46. Medlej-Hashim M, Petit I, Adib S et al. Familial Mediterranean fever : association of elevated IgD plasma levels with specific MEFV mutations. European Journal of Human Genetics 2001 ; 9 : 849-54.
47. Cazaneuve C, Sarkisian T, Pecheux C et al. MEFV-gene analysis in Armenian patients with familial Mediterranean fever : diagnostic value and unfavourable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet 1999 ; 65 : 88-97.
48. Timmann C, Muntau B, Kuhne K, Gelhaus A, Horstmann RD. Two novel mutations R653H and E230K in the Mediterranean fever gene associated with disease. Mutation Research 2001 ; 479 : 235-9.
49. Medlej-Hashim M, Delague V, Chouery E et al. Amyloidosis in familial Mediterranean fever patients : correlation with MEFV genotype and SAA1 and MICA polymorphisms effects. BMC Medical Genetics 2004 ; 5 : 4.
50. Zaks N, Shinar Y, Padeh S et al. Analysis of the three most common MEFV mutations in 412 patients with familial Mediterranean fever. Isr Med Assoc J 2003 ; 5 : 585-8.
51. Mansour I, Delague V, Cazaneuve C et al. Familial Mediterranean fever in Lebanon : mutation spectrum, evidence for cases in Maronites, Greek orthodoxies, Greek catholics, Syriacs and Chiites and for an association between amyloidosis and M694V and M694I mutations. European Journal of Human Genetics 2001 ; 9 : 51-5.
52. Stojanov S, Kastner DL. Familial autoinflammatory diseases : genetics, pathogenesis and treatment. Current Opinion in Rheumatology 2005 ; 17 : 586-99.
53. Tchernitchko D, Legendre M, Cazaneuve C, Delahaye A, Niel F, Amselm S. The E148Q MEFV allele is not implicated in the development of familial Mediterranean fever. Hum Mutat 2003 ; 22 : 339-40.
54. Tchernitchko DO, Giirard-Blanluet M, Legendre M, Cazaneuve C, Grateau G, Amselm S. Intrafamilial segregation analysis of the p.E148Q MEFV allele in familial Mediterranean fever. Ann Rheum Dis 2006 ; 65 : 1154-7.
55. Rabinovitch E, Livneh A, Langevitz P et al. Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene. Ann Rheum Dis 2005 ; 64 : 1009-14.
56. Fisher PW, Ho LT, Goldshmidt R, Semerdjian R, Rutecki GW. Familial Mediterranean fever, inflammation and nephrotic syndrome : fibrillary glomerulopathy and the M680I missense mutation. BMC Nephrology 2003 ; 4 : 6.
57. Goldfinger SE. Colchicine for familial Mediterranean fever. New England Journal of Medicine 1972 ; 287 : 1302.
58. Ben-Chetrit E, Levy M. Colchicine 1998 : Update. Semin Arthritis Rheum 1998 ; 28 : 48-59.
59. Cerquaglia C, Diaco M, Nucera G, La Regina M, Montalto M, Manna R. Pharmacological and clinical basis of treatment of familial Mediterranean fever (FMF) with colchicine or analogues : an update. Current Drug Targets - Inflammation & Allergy 2005 ; 4 : 117-24.
60. Ben-Chetrit E, Bergmann S, Sood R. Mechanism of the anti-inflammatory effect of colchicine in rheumatic diseases : a possible new outlook through microarray analysis. Rheumatology 2005 ; 45 : 274-82.
61. Klimeecki WT, Futscher BW, Grogan TM, Dalton WS. P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood 1994 ; 84 : 2451-8.
62. Lidar M, Schermann JM, Shinar Y et al. Colchicine non-responsiveness in familial Mediterranean fever : Clinical, genetic, pharmacokinetic, and socio-economic characterization. Clin Exp Rheumatol 2004 ; 22 : 791-2.
63. Mijatovic V, Hompes PGA, Wouters MGAJ. Familial Mediterranean fever and its implications for fertility and pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology 2003 ; 108 : 171-6.
64. Calguneri M, Apras S, Ozbalkan Z, Ozturk MA, Ertenli I, Kiraz S. The efficacy of continuous interferon-α administration as an adjunctive agent to colchicine-resistant familial Mediterranean fever patients. Clin Exp Rheumatol 2004 ; 22 : S41-S44.
65. Milledge J, Shaw PJ, Mansour A et al. Allogenic bone marrow transplantation: cure for familial Mediterranean fever. Blood 2002 ; 100 : 774-7.
66. Touitou I, Ben-Chetrit E, Gershoni-Baruch R et al. Allogenic bone marrow transplantation : not a treatment yet for familial Mediterranean fever. Blood 2003 ; 102 : 409.
67. Simon A, van der Meer JWM, Vesely R, Myrdal U, Yoshimura K, Duys P, Drenth JPH, and contributing members of the International HIDS study group. Approach to genetic analysis in the diagnosis of hereditary autoinflammatory syndromes. Rheumatology (Oxford) 2005 ; 45 : 269-73.